Overview

Phase 1 Study of ELX-02 in Healthy Adults

Status:
Completed
Trial end date:
2017-12-15
Target enrollment:
Participant gender:
Summary
Phase 1 Single Ascending Dose Study in Normal Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Eloxx Pharmaceuticals, Inc.
Collaborators:
SGS Life Sciences
SGS Life Sciences, a division of SGS Belgium NV